Pathway-based polygene risk for severe depression implicates drug metabolism in CONVERGE. The Psychiatric Genomics Consortium (PGC) has made major advances in the molecular etiology of MDD, confirming that MDD is highly polygenic.
Pathway-based polygene risk for severe depression implicates drug metabolism in CONVERGE. The Psychiatric Genomics Consortium (PGC) has made major advances in the molecular etiology of MDD, confirming that MDD is highly polygenic.